Antimalarial dosing regimens and drug resistance

Area of Science:

• Pharmacology
• Infectious Diseases
• Global Health

Background:

• Antimalarial treatment failure is a significant global health concern.
• Current dosing regimens are primarily based on non-pregnant adults, neglecting key populations.
• Pregnant women and young children experience higher treatment failure rates and bear a substantial malaria burden.

Purpose of the Study:

• To highlight the underappreciated role of underdosing in antimalarial treatment failure.
• To emphasize the need for optimized antimalarial drug dosages in infants, young children, and pregnant women.
• To address the urgent requirement for studies investigating higher dosages in these vulnerable groups.

Main Methods:

• Review of existing literature on antimalarial drug concentrations in different patient populations.
• Analysis of treatment failure rates in relation to demographic factors (age, pregnancy status).
• Identification of knowledge gaps regarding optimal dosing in pediatric and pregnant populations.

Main Results:

• Blood concentrations of many antimalarial drugs are significantly lower in pregnant women and young children compared to non-pregnant adults.
• Sub-therapeutic drug concentrations are linked to poorer treatment responses.
• Existing dosing regimens may inadvertently contribute to the emergence and spread of antimalarial drug resistance.

Conclusions:

• Underdosing is a critical, underappreciated factor in antimalarial treatment failure.
• Optimizing antimalarial dosages in infants, young children, and pregnant women is essential for improving cure rates.
• Research into higher, optimized dosages is urgently needed to prolong the efficacy of antimalarial drugs and combat resistance.